Navigation Links
Controlling gene expression: How chromatin remodelers block a histone pass
Date:8/26/2012

o important roles to ensure that RNA transcription starts only at the beginning of the gene and not in the middle," says Workman. "On one hand, it recruits Isw1 to block incoming histones, and on the other it also recruits a deacetylase to remove any acetylation marks that might happen to have sneaked in."

The Workman lab uses yeast, fruit flies and mammalian cells to study multiple factors that activate and repress transcription. Thus far, they have characterized players in the repressive Set2 pathway primarily in yeast, in part because yeast represents an ideal organism for mutational analysis and has a fairly small genome6,000 genes compared to the 25,000 or so in humans or mice.

Smolle notes that although yeast genomes are simpler, the principles that govern Set2 activity in yeast will likely hold true for its human counterparts, among them the human protein SETD2. "Yeast has a single methylase, while humans have several, and flies and humans have several Isw1-like proteins," she says. "While you cannot equate one with the other precisely, you can be reasonably sure that what happens in yeast happens in humans as well but tends to be more complicated."

Workman agrees, adding that these discoveries have significant implications for human disease. "Strikingly, the human homolog of Set2, SETD2, is implicated as a tumor suppressor in breast cancer and in renal carcinoma, and those cells are deficient in the SETD2 methylation mark," he says. "These findings strongly suggest that SETD2 could be important in controlling cell growth and preventing tumors. Thanks to yeast, we now know more about how Set2 does that."


'/>"/>
Contact: Gina Kirchweger
gxk@stowers.org
816-806-1036
Stowers Institute for Medical Research
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Controlling gene expression with hydrogen peroxide switches
2. Controlling inflammatory and immune responses
3. Manipulating chromatin loops to regulate genes may offer future treatments for blood diseases
4. Crystal structure of archael chromatin clarified in new study
5. Mathematicians find solution to biological building block puzzle
6. Under the right conditions, peptide blocks HIV infection at multiple points along the way
7. Blood-brain barrier building blocks forged from human stem cells
8. Hulk smash? Maybe not anymore: scientists block excess aggression in mice
9. Stanford marine biologist Barbara Block wins Rolex Award for Enterprise
10. Stealing lifes building blocks
11. Blocking DNA: HDAC inhibitor targets triple negative breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Controlling gene expression: How chromatin remodelers block a histone pass
(Date:6/19/2013)... , June 19, 2013  New York College of ... United States Patent and Trademark Office for detecting biometric ... reflect whether guards have been injured, attacked or killed. ... portfolio under the Intellectual Properties Agreements of New York ... , President of New York ...
(Date:6/19/2013)... Elsevier, a world-leading provider of scientific, technical and medical ... launch of a new open access journal, GeoResJ ... , Elsevier,s earth and planetary science journals portfolio has ... to provide a forum for rapid publication of top ... will be co-edited by six Executive Editors, each covering ...
(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...
Breaking Biology News(10 mins):New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 2New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 3New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed 4UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... 2 emissions from using coal are set to double by ... mitigating global climate change. In view of the essential role ... emissions where coal is used. The British Geological ... (NZEC) Phase 1 study in Beijing, China today. The aim of ...
... small amounts of lead in children,s blood -- amounts ... with reduced IQ scores, finds a new six-year Cornell ... on cognitive function in children whose blood-lead levels (BLLs) ... (CDC) standard of 10 micrograms per deciliter (mcg/dl) -- ...
... dengue cause suffering and death around the world. ... and is particularly devastating in children under the age ... these diseases consume vast economic resources in the very ... to controlling these diseases such as insecticides, vaccine development, ...
Cached Biology News:UK scientists lead China closer to carbon capture and storage 2Even minute levels of lead cause brain damage in children 2Selfish DNA and the Genetic Control of Vector-Borne Diseases 2Selfish DNA and the Genetic Control of Vector-Borne Diseases 3
(Date:6/19/2013)... Clinverse, Inc. , a global ... today announced it will be exhibiting and showcasing ... Boston, June 24-26, 2013. Clinverse’s eClinical Commerce ... configurable, cloud-based clinical financial lifecycle system. , Clinverse’s ... eClinical Commerce Network, automates site contract set-up and ...
(Date:6/19/2013)... 19, 2013   NineSigma , Inc., of ... following its launch, NineSights.com is now the ... for the worldwide community of innovators. From ... sustainability experts, NineSights stands out for its large community ... and technical disciplines, all vetted by NineSigma. The community ...
(Date:6/19/2013)... India , June 19, ... Bharat Book Bureau presents Innovative ... and Formulation Technology Licensing Opportunities ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) There ... or controlled release drugs approved ...
(Date:6/19/2013)... 18, 2013 A new look at ... and other trends will highlight technical sessions at ... fall. In its 33rd year, the three-day event is ... of key suppliers, approximately 100 technical presentations and numerous ... international society for optics and photonics , the meeting ...
Breaking Biology Technology:Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
... (Nasdaq: PRXL ), a leading global ... Ltd, today announced,that it has been recognized ... as,the winner of its Most Innovative Patient ... collaborative efforts of PAREXEL and study,sponsor Glenmark, ...
... AMSTERDAM, October 29 Avantium announced today ... private financing round. Avantium,is active in the ... biofuel and bioplastic, and the improvement of,pharmaceutical ... accelerate its two,proprietary development programs. The focus ...
... Oct. 29 ,Shire plc (LSE: SHP, Nasdaq: SHPGY) the global specialty ... Q3 2008 Financial Highlights, - Product sales up ... up 51% to $444 million - New product sales(1) $276 ... - Total revenues up 28% to $779 million - Non ...
Cached Biology Technology:PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy 2PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy 3PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy 4PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy 5Avantium Completes EUR 18 Million Financing Round 2Avantium Completes EUR 18 Million Financing Round 3Avantium Completes EUR 18 Million Financing Round 4Shire's New Product Portfolio Delivers Strong Quarterly Performance 2Shire's New Product Portfolio Delivers Strong Quarterly Performance 3Shire's New Product Portfolio Delivers Strong Quarterly Performance 4Shire's New Product Portfolio Delivers Strong Quarterly Performance 5Shire's New Product Portfolio Delivers Strong Quarterly Performance 6Shire's New Product Portfolio Delivers Strong Quarterly Performance 7Shire's New Product Portfolio Delivers Strong Quarterly Performance 8Shire's New Product Portfolio Delivers Strong Quarterly Performance 9Shire's New Product Portfolio Delivers Strong Quarterly Performance 10Shire's New Product Portfolio Delivers Strong Quarterly Performance 11Shire's New Product Portfolio Delivers Strong Quarterly Performance 12Shire's New Product Portfolio Delivers Strong Quarterly Performance 13Shire's New Product Portfolio Delivers Strong Quarterly Performance 14Shire's New Product Portfolio Delivers Strong Quarterly Performance 15Shire's New Product Portfolio Delivers Strong Quarterly Performance 16Shire's New Product Portfolio Delivers Strong Quarterly Performance 17Shire's New Product Portfolio Delivers Strong Quarterly Performance 18Shire's New Product Portfolio Delivers Strong Quarterly Performance 19Shire's New Product Portfolio Delivers Strong Quarterly Performance 20Shire's New Product Portfolio Delivers Strong Quarterly Performance 21Shire's New Product Portfolio Delivers Strong Quarterly Performance 22Shire's New Product Portfolio Delivers Strong Quarterly Performance 23Shire's New Product Portfolio Delivers Strong Quarterly Performance 24Shire's New Product Portfolio Delivers Strong Quarterly Performance 25Shire's New Product Portfolio Delivers Strong Quarterly Performance 26Shire's New Product Portfolio Delivers Strong Quarterly Performance 27Shire's New Product Portfolio Delivers Strong Quarterly Performance 28Shire's New Product Portfolio Delivers Strong Quarterly Performance 29
Mouse polyclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = 25797...
... against a partial recombinant IFNA2. Immunogen: ... protein is produced in E. coli. The ... mg. OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
... Researchers no longer need to perform time consuming ... With Mutation Surveyor, any found variants of the ... clearly indicated in our mutation electropherogram as a ... the bi-directional analysis mode is over 99%, with ...
...
Biology Products: